[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hemophilia-a":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":212,"states":224},"Hemophilia A",33,27,[8,16,22,28,35,42,48,55,61,67,73,79,85,91,96,102,108,114,120,126,132,138,144,150,156,162,168,174,181,187,193,199,205],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05685238","A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A",[12],"Phase 3","RECRUITING","2026-08-26T02:15:15.642947Z","2026-07-05T03:45:20.247359Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07416604","A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A",[12],"2026-08-26T02:18:38.865010Z","2026-05-13T02:55:06.702455Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT05145127","Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors",[12],"2026-08-26T02:19:24.527214Z","2026-05-05T02:47:14.264260Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":33,"content_modified":34},"NCT07220564","A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A",[32],"Phase 1","2026-08-26T02:16:35.654046Z","2026-05-05T02:43:29.541199Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT04567511","Hemlibra in Mild Hemophilia A",[39],"Phase 4","2026-08-26T02:18:13.438956Z","2026-05-05T02:43:29.500742Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT04563520","SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis",[12],"2026-08-26T02:18:41.390601Z","2026-05-05T02:43:29.467183Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":53,"content_modified":54},"NCT07226206","A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A",[52],"Phase 1\u002FPhase 2","2026-08-26T02:15:00.557154Z","2026-05-05T02:43:29.232409Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT06703606","A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.",[32],"2026-08-26T02:15:14.574786Z","2026-05-05T02:43:28.487834Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT06941870","Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy",[39],"2026-08-26T02:17:52.450442Z","2026-05-05T02:43:28.469973Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT05936580","Nuwiq Dosing and Outcomes In the ManagEment of Women\u002FGirls With Haemophilia A Needing FVIII Treatment for Surgery",[39],"2026-08-26T02:17:39.048487Z","2026-05-05T02:43:28.191088Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT07285460","A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B",[12],"2026-08-26T02:17:46.653867Z","2026-05-05T02:43:27.842950Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT04647227","SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors",[39],"2026-08-26T02:17:49.709549Z","2026-05-05T02:43:27.660676Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06145373","A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab",[39],"2026-08-26T02:18:48.678868Z","2026-05-05T02:43:27.640453Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":71,"content_modified":95},"NCT05987449","A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A",[52],"2026-05-05T02:43:26.727335Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT05935358","Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study",[39],"2026-08-26T02:15:13.282904Z","2026-05-05T02:35:31.897047Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT05611801","A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B",[12],"2026-08-26T02:19:15.498463Z","2026-05-05T02:35:31.704024Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT05500807","Emicizumab for Severe Von Willebrand Disease (VWD) and VWD\u002FHemophilia A",[32],"2026-08-26T02:18:15.214990Z","2026-04-29T02:57:57.144802Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT04676048","ASC618 Gene Therapy in Hemophilia A Patients",[52],"2026-08-26T02:17:27.435233Z","2026-04-29T02:57:57.117316Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":124,"content_modified":125},"NCT06349473","A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)",[32],"2026-08-26T02:15:38.131683Z","2026-05-05T02:43:27.336527Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT07414511","Hemophilia A Research Program",[],"2026-08-26T02:15:51.395565Z","2026-05-13T02:55:06.701372Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT05022459","Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis",[],"2026-08-26T02:16:02.918558Z","2026-05-13T02:55:06.278798Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":142,"content_modified":143},"NCT04131036","Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A",[],"2026-08-26T02:17:23.750999Z","2026-05-13T02:55:06.243016Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT04023019","Treatment of Hemophilia A Patients With FVIII Inhibitors",[],"2026-08-26T02:18:17.950264Z","2026-05-13T02:55:06.182752Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT03695978","Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients",[],"2026-08-26T02:16:59.895916Z","2026-05-13T02:55:06.175949Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":160,"content_modified":161},"NCT06820515","ATHNdataset Registry",[],"2026-08-26T02:17:50.500039Z","2026-05-13T02:55:06.581598Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT04398628","ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders",[],"2026-08-26T02:18:22.309547Z","2026-05-13T02:55:06.248627Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT05568719","Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively",[12],"2026-08-26T02:15:01.639696Z","2026-05-05T02:43:29.389047Z",{"nct_id":175,"title":176,"phases":177,"status":178,"updated_at":179,"content_modified":180},"NCT07158606","Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction",[39],"NOT_YET_RECRUITING","2026-08-26T02:17:44.240289Z","2026-05-05T02:43:29.140234Z",{"nct_id":182,"title":183,"phases":184,"status":178,"updated_at":185,"content_modified":186},"NCT07692217","TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies",[],"2026-08-26T02:18:09.641312Z","2026-07-19T19:36:05.152422Z",{"nct_id":188,"title":189,"phases":190,"status":178,"updated_at":191,"content_modified":192},"NCT05932914","Liver Biopsy Following Gene Therapy For Hemophilia",[],"2026-08-26T02:15:27.567165Z","2026-05-13T02:55:06.395708Z",{"nct_id":194,"title":195,"phases":196,"status":178,"updated_at":197,"content_modified":198},"NCT07421154","Study of a Smart Sharps Disposal Device in Patients With Hemophilia",[],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:26.904359Z",{"nct_id":200,"title":201,"phases":202,"status":203,"updated_at":160,"content_modified":204},"NCT05768386","A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)",[],"ENROLLING_BY_INVITATION","2026-06-16T05:54:08.086333Z",{"nct_id":206,"title":207,"phases":208,"status":209,"updated_at":210,"content_modified":211},"NCT03655223","Early Check: Expanded Screening in Newborns",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:53:57.297126Z","2026-06-16T05:54:07.977837Z",[213,217,221],{"biomarker":214,"count":215,"slug":216},"F8 wt Allele",10,"f8-wt-allele",{"biomarker":218,"count":219,"slug":220},"Coagulation Factor VIII",3,"coagulation-factor-viii",{"biomarker":222,"count":219,"slug":223},"FVIII inhibitor","fviii-inhibitor",[225,229,233,236,239,243,247,250,253,257,260,263,267,270,274,277,280,283,286,289,292,295],{"state":226,"count":227,"slug":228},"California",16,"california",{"state":230,"count":231,"slug":232},"Florida",9,"florida",{"state":234,"count":231,"slug":235},"Indiana","indiana",{"state":237,"count":231,"slug":238},"Pennsylvania","pennsylvania",{"state":240,"count":241,"slug":242},"Texas",8,"texas",{"state":244,"count":245,"slug":246},"Iowa",7,"iowa",{"state":248,"count":245,"slug":249},"Michigan","michigan",{"state":251,"count":245,"slug":252},"Washington","washington",{"state":254,"count":255,"slug":256},"Missouri",6,"missouri",{"state":258,"count":255,"slug":259},"North Carolina","north-carolina",{"state":261,"count":255,"slug":262},"Ohio","ohio",{"state":264,"count":265,"slug":266},"Georgia",5,"georgia",{"state":268,"count":265,"slug":269},"Illinois","illinois",{"state":271,"count":272,"slug":273},"Arkansas",4,"arkansas",{"state":275,"count":272,"slug":276},"Colorado","colorado",{"state":278,"count":272,"slug":279},"New York","new-york",{"state":281,"count":272,"slug":282},"Tennessee","tennessee",{"state":284,"count":219,"slug":285},"District of Columbia","district-of-columbia",{"state":287,"count":219,"slug":288},"Louisiana","louisiana",{"state":290,"count":219,"slug":291},"Massachusetts","massachusetts",{"state":293,"count":219,"slug":294},"Nevada","nevada",{"state":296,"count":219,"slug":297},"Wisconsin","wisconsin"]